CannLabs, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CANL research report →
Price Chart
About the company
CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing.
- CEO
- Mark C. Mirken
- IPO
- 2012
- Employees
- 37
- HQ
- Denver, CO, US
Get TickerSpark's AI analysis on CANL
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $93.32K
- P/E
- 0.09
- PEG
- -0.00
- P/S
- 0.02
- P/B
- 0.03
- EV/EBITDA
- -0.63
- Div Yield
- 0.00%
- Gross Margin
- 46.97%
- Op Margin
- 19.86%
- Net Margin
- 19.79%
- ROE
- 37.82%
- ROIC
- 27.67%
Latest fiscal year · YoY change
- Revenue
- $4.39M+38.0%
- Gross Profit
- $2.06M+21.4%
- Op Income
- $872.24K
- Net Income
- $869.17K+21.9%
- EPS
- $0.00+22.2%
- OCF Growth
- +44.8%
- FCF Growth
- +44.8%
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.40
- RSI (14)
- 52
- Avg Volume
- 795
No earnings-call transcripts are available for CANL yet.
- Free Float
- 55.0%
- Shares Outstanding
- 933.16M
- Float Shares
- 512.92M
Our CANL coverage
Recent articles, reports, and earnings notes.
No research on CANL yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CANL report →Contrasting NeuroOne Medical Technologies (NASDAQ:NMTC) and Cannlabs (OTCMKTS:CANL)
defenseworld.net · Jan 28
PACS Group (NYSE:PACS) and Cannlabs (OTCMKTS:CANL) Head to Head Analysis
defenseworld.net · Jan 5
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.